Logo image of REFR

RESEARCH FRONTIERS INC (REFR) Stock Fundamental Analysis

NASDAQ:REFR - US7609111072 - Common Stock

1.398 USD
+0.02 (+1.3%)
Last: 8/26/2025, 4:30:01 PM
Fundamental Rating

2

REFR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. REFR has a great financial health rating, but its profitability evaluates not so good. REFR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year REFR has reported negative net income.
In the past year REFR has reported a negative cash flow from operations.
REFR had negative earnings in each of the past 5 years.
In the past 5 years REFR always reported negative operating cash flow.
REFR Yearly Net Income VS EBIT VS OCF VS FCFREFR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -27.77%, REFR is doing worse than 75.00% of the companies in the same industry.
With a Return On Equity value of -43.12%, REFR is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -27.77%
ROE -43.12%
ROIC N/A
ROA(3y)-43.92%
ROA(5y)-42.03%
ROE(3y)-53.41%
ROE(5y)-50.62%
ROIC(3y)N/A
ROIC(5y)N/A
REFR Yearly ROA, ROE, ROICREFR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

REFR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REFR Yearly Profit, Operating, Gross MarginsREFR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

7

2. Health

2.1 Basic Checks

REFR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REFR has more shares outstanding
Compared to 5 years ago, REFR has more shares outstanding
REFR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REFR Yearly Shares OutstandingREFR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
REFR Yearly Total Debt VS Total AssetsREFR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

REFR has an Altman-Z score of -25.86. This is a bad value and indicates that REFR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -25.86, REFR is doing worse than 96.77% of the companies in the same industry.
REFR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -25.86
ROIC/WACCN/A
WACC9.53%
REFR Yearly LT Debt VS Equity VS FCFREFR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

REFR has a Current Ratio of 11.96. This indicates that REFR is financially healthy and has no problem in meeting its short term obligations.
REFR has a Current ratio of 11.96. This is amongst the best in the industry. REFR outperforms 94.35% of its industry peers.
REFR has a Quick Ratio of 11.96. This indicates that REFR is financially healthy and has no problem in meeting its short term obligations.
REFR has a Quick ratio of 11.96. This is amongst the best in the industry. REFR outperforms 95.16% of its industry peers.
Industry RankSector Rank
Current Ratio 11.96
Quick Ratio 11.96
REFR Yearly Current Assets VS Current LiabilitesREFR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.44% over the past year.
Looking at the last year, REFR shows a very strong growth in Revenue. The Revenue has grown by 21.77%.
The Revenue has been decreasing by -5.08% on average over the past years.
EPS 1Y (TTM)44.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)21.77%
Revenue growth 3Y-1.91%
Revenue growth 5Y-5.08%
Sales Q2Q%-73.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
REFR Yearly Revenue VS EstimatesREFR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
REFR Yearly EPS VS EstimatesREFR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 -0.05 -0.1 -0.15 -0.2

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for REFR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REFR Price Earnings VS Forward Price EarningsREFR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REFR Per share dataREFR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

REFR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RESEARCH FRONTIERS INC

NASDAQ:REFR (8/26/2025, 4:30:01 PM)

1.398

+0.02 (+1.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners16.55%
Inst Owner Change-2.76%
Ins Owners9.21%
Ins Owner Change0%
Market Cap47.04M
Analysts82.86
Price TargetN/A
Short Float %1.08%
Short Ratio9.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 29.74
P/FCF N/A
P/OCF N/A
P/B 19.39
P/tB 19.39
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.05
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.77%
ROE -43.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-43.92%
ROA(5y)-42.03%
ROE(3y)-53.41%
ROE(5y)-50.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.02%
Cap/Sales 0.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.96
Quick Ratio 11.96
Altman-Z -25.86
F-Score6
WACC9.53%
ROIC/WACCN/A
Cap/Depr(3y)3.98%
Cap/Depr(5y)19.53%
Cap/Sales(3y)0.1%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.77%
Revenue growth 3Y-1.91%
Revenue growth 5Y-5.08%
Sales Q2Q%-73.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y54.43%
OCF growth 3YN/A
OCF growth 5YN/A